<DOC>
	<DOCNO>NCT01087203</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety investigational drug , tanezumab , adult patient painful diabetic peripheral neuropathy .</brief_summary>
	<brief_title>A Study Of The Analgesic ( Pain-Relief ) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description>This study terminate 18 November 2010 follow US FDA clinical hold tanezumab diabetic peripheral neuropathy clinical study halt dose enrollment patient 19 July 2010 potential safety issue .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Diagnosis diabetes mellitus ( high blood sugar ) HbA1c level ≤11 % Screening , stable antidiabetic medication regimen 30 day prior randomization . Diagnosis diabetic peripheral neuropathy pain legs foot decrease sensation foot decreased/absent ankle jerk/ reflex . Presence ongoing pain due diabetic peripheral neuropathy least 3 month . A pain score great equal ( ≥ ) 4 diabetic peripheral neuropathy Numerical Rating Scale ( NRS ) , 11point scale 0 meaning pain 10 meaning worst pain Screening . Be willing stop pain medication diabetic peripheral neuropathy except limited use acetaminophen ( Tylenol ) ibuprofenlike ( Motrin ) medication Screening Baseline use prohibit pain medication throughout duration study except permit study guideline . Painful neuropathy diabetic peripheral neuropathy . Other type diabetic neuropathy . Patients past history carpal tunnel syndrome ( CTS ) sign symptom CTS one year prior Screening eligible participation . Patients fibromyalgia , regional pain cause lumbar cervical compression radiculopathy moderate severe pain . Patients present ( current ) history sciatica eligible participation . The presence pain condition distinguish diabetic peripheral neuropathy peripheral vascular disease . Amputations dues diabetes . Patient clinically significant medical condition laboratory abnormality . History , diagnosis , sign symptom clinically significant neurological disease ( Alzheimer 's disease , head trauma , epilepsy stroke ) . History , diagnosis , sign symptom clinically significant psychiatric disease ( bipolar disorder schizophrenia ) . History known alcohol , analgesic drug abuse within 2 year Screening . Pregnant woman , lactate mother , woman suspect pregnant , woman wish pregnant course clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>diabetic peripheral neuropathy</keyword>
	<keyword>tanezumab</keyword>
	<keyword>diabetic neuropathy</keyword>
	<keyword>diabetic polyneuropathy</keyword>
	<keyword>diabetic neuropathy painful</keyword>
</DOC>